Skip to main content
. 2021 Dec 21;43:101233. doi: 10.1016/j.eclinm.2021.101233

Table 3.

Pooled prevalence and subgroup analyses of anxiety.

Outcome measure Study (N) Sample (N) Prevalence(95%CI) I2%
Anxiety ≤one month 19 3,377 41.9 (30.9, 53.0) 98.2
Study setting
High-income countries 14 2,256 36.0 (25.5, 46.5) 96.8
Middle-income countries 5 1,121 54.7 (24.8, 84.5) 99.0
Study design
Cohort 13 2,226 40.8 (25.6, 56.0) 98.5
Cross-sectional 6 1,151 41.1 (25.3, 54.0) 96.7
Selection bias- Sample representativeness
Representative 6 1,398 48.7 (27.3, 70.1) 98.3
Non-representative 13 1,462 37.4 (24.7, 50.0) 97.5
Anxiety symptoms
Self-reported 15
Parents*
Mothers 19 2,708 42.3 (30.7, 54.0) 97.6
Fathers 6 669 22.9 (13.1, 32.8) 93.39
Prematurity a
GA 23 - 41 weeks 11 2,372 37.3 (27.5, 47.2.6) 96.6
GA <33 weeks 8 878 50.0 (34.9, 66.0) 96.0
Measuring scales*
STAI-State b 9 892 52.3 (39.7, 67.9) 96.3
Other scales 9 2,456 32.2 (21.1, 42.4) 97.1
Anxiety > 1 month < 1 years 4 481 26.3 (10.1, 42.5) 94.9
Study Setting 4 in high-income countries
Study design*
Cohort 3 292 33 (20.1, 45.8) NA
Cross-sectional 1 189 6.9 (3,71, 11.5) NR
Selection bias - Sample representativeness*
Representative 1 189 6.9 (3.71, 11.5) NA
Non-representative 3 292 33 (20.1, 45.8) NR
Anxiety symptoms*
Clinical interview 1 189 6.9 (3.71, 11.5) NA
Self-reported 3 292 33 (20.1, 45.8) NR
Parents*
Mothers 4 329 27.7 (12.0, 43.4) 91.6
Fathers 2 152 4.8 (1.6, 8.1) NR
Prematurity*
GA < 37 weeks 1 189 6.9 (3.71, 11.5) NR
GA <33 weeks 3 292 33 (20.1, 45.8) NR
Scales*
STAI-State 2 137 39.3 (31.2 to 47.5) NR
Other scales 2 344 10.5 (7.3, 13.7) NR
Anxiety > 1 year 1 27 0 NA

Abbreviations: a Bonacquisti 2020 not included as gestational age (GA) not reported & Trumello 2018 provided data for both subgroups.

b

Misund 2014 not included; *p<0.05: Significant difference between subgroups; NR: Not reported -few studies to calculate heterogeneity; NA: Not applicable.